Skip to main content
. 2014 Jan 25;51(9):1724–1736. doi: 10.1007/s13197-014-1257-2

Table 4.

Effect of BGO nanoemulsion comprising ESA and sunflower oil fed diabetic rats at 20 % fat in diet on lipid peroxidation of plasma, erythrocyte membrane and liver tissue lipids

Group Fat diet Plasma lipid peroxidation (nmole of MDA/mL) Erythrocyte membrane lipid peroxidation (nmole of MDA/mL) Liver tissue lipid peroxidation (nmole of MDA/mL)
Control (non-diabetic) SO 10.71 ± 0.414# 6.64 ± 0.44# 1.62 ± 0.34#
Diabetic groups SO 27.21 ± 0.35 15.23 ± 0.26 3.4 ± 0.62
SO+ 0.5 % ESA NEa 5.34 ± 0.25* 3.26 ± 0.17* 1.42 ± 0.81*
SO+ 0.25 % ESA NEb 4.8 ± 0.33* 2.83 ± 0.91* 1.28 ± 0.33*
SO+ 0.5 % ESA CEc 5.2 ± 0.32* 4.23 ± 0.42* 1.73 ± 0.63*
SO+ 0.25 % ESA CEd 6.12 ± 0.27* 4.4 ± 0.31* 2.5 ± 0.24*
[MDA] comparison among diet groups ALX(SO)>CON(SO)>0.25 % ESA CE>0.5 % ESA NE>0.5 % ESA CE >0.25 % ESA NE

Values are mean ± SEM, n = 6

(ALX-D) treated diabetic group fed with sunflower oil

SO sunflower oil; BGO bitter gourd oil; ESA α-eleostearic acid; NE nanoemulsion

*Marked results show mean values for the BGO NE treated experimental groups that are statistically different (p < 0.05) than the alloxan (ALX-D) treated diabetic group fed with sunflower oil diet.

#Marked results show mean values for the non diabetic control group that are statistically different (p < 0.05) than the alloxan

a0.5 % ESA NE is present in 1 % BGO NE; b0.25 % ESA NE is present in 0.5 % BGO NE; c0.5 % ESA CE is present in 1 % BGO CE; d0.25 % ESA CE is present in 0.5 % ESA CE